ABVC BIOPHARMA, INC. Annual Share-based Payment Arrangement, Expense in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Abvc Biopharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2022.
  • Abvc Biopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $0.000.
  • Abvc Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.04M, a 32.6% increase from 2021.
  • Abvc Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.31M, a 28% increase from 2020.
  • Abvc Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $4.15M, a 18485% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $7.04M +$1.73M +32.6% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 $5.31M +$1.16M +28% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $4.15M +$4.12M +18485% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $22.3K -$6.49K -22.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $28.8K -$109K -79.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-05-15
2017 $138K -$260K -65.3% Oct 1, 2016 Sep 30, 2017 10-KT 2018-04-13
2016 $398K Oct 1, 2015 Sep 30, 2016 10-KT 2018-04-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.